LIN
NASDAQ · Chemicals
Linde Plc
$448.24
-11.45 (-2.49%)
Income Statement
| FY 2026 | FY 2026 | FY 2025 | FY 2025 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | 33.61B | 33.61B | 33.40B | 33.40B | 83.86B |
| Net Income | 6.82B | 6.82B | 6.10B | 6.10B | 10.34B |
| EPS | — | — | — | — | — |
| Profit Margin | 20.3% | 20.3% | 19.3% | 19.3% | 12.3% |
| Rev Growth | +0.6% | +0.6% | +0.6% | +0.6% | -7.7% |
Balance Sheet
| FY 2026 | FY 2026 | FY 2025 | FY 2025 | FY 2025 | |
|---|---|---|---|---|---|
| Total Debt | 43.30B | 43.30B | 43.30B | 43.30B | 52.55B |
| Total Equity | 61.35B | 61.35B | 61.35B | 61.35B | 176.23B |
| D/E Ratio | 0.71 | 0.71 | 0.71 | 0.71 | 0.30 |
Cash Flow
| FY 2026 | FY 2026 | FY 2025 | FY 2025 | FY 2025 | |
|---|---|---|---|---|---|
| EBITDA | 12.77B | 12.77B | 12.06B | 12.06B | 12.75B |
| Free Cash Flow | — | — | — | — | 7.13B |